Tanja Weis

1.8k total citations
16 papers, 296 citations indexed

About

Tanja Weis is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Tanja Weis has authored 16 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Tanja Weis's work include Cardiac electrophysiology and arrhythmias (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Tanja Weis is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Tanja Weis collaborates with scholars based in Germany, United States and Netherlands. Tanja Weis's co-authors include Hugo A. Katus, Henning Witt, Erik Peter, Philipp Schatz, Dietrich Rein, J. Wiemer, Bianca Bethan, Inken Padberg, Volker Liebenberg and Matthias Mueller and has published in prestigious journals such as PLoS ONE, Clinical Chemistry and Life Sciences.

In The Last Decade

Tanja Weis

16 papers receiving 291 citations

Peers

Tanja Weis

CCM

PHYSI

PHEOH

Margaret Nelson United States

Jijin Lin China

Kousuke Seiki Japan

E.P. Dawson United States

Rosienne Farrugia Malta

Anna V. Zetterqvist Sweden

Mohsen Fathzadeh United States

Jana Wobst Germany

Bryan Wilson United States

Wanying Pan China

Margaret Nelson United States

Tanja Weis

136 ×0.8

52 ×0.5

CCM

103 ×2.2

PHYSI

20 ×0.7

12 ×0.4

PHEOH

Citations per year, relative to Tanja Weis Tanja Weis (= 1×) peers Margaret Nelson

Countries citing papers authored by Tanja Weis

Since Specialization

Citations

This map shows the geographic impact of Tanja Weis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Weis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Weis more than expected).

Fields of papers citing papers by Tanja Weis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Weis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Weis. The network helps show where Tanja Weis may publish in the future.

Co-authorship network of co-authors of Tanja Weis

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Weis. A scholar is included among the top collaborators of Tanja Weis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Weis. Tanja Weis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kayvanpour, Elham, Farbod Sedaghat‐Hamedani, Tanja Weis, et al.. (2024). Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes. Biomolecules. 14(9). 1137–1137. 4 indexed citations

Oeing, Christian U., Mark E. Pepin, Yassen Assenov, et al.. (2023). Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure. Basic Research in Cardiology. 118(1). 9–9. 9 indexed citations

Rahm, Ann‐Kathrin, Tanja Weis, Patrick Most, et al.. (2021). Differential regulation of K _Ca 2.1 ( KCNN1 ) K ⁺ channel expression by histone deacetylases in atrial fibrillation with concomitant heart failure. Physiological Reports. 9(11). e14835–e14835. 10 indexed citations

Rahm, Ann‐Kathrin, Patrick Most, Tanja Weis, et al.. (2021). Trigger-Specific Remodeling of KCa2 Potassium Channels in Models of Atrial Fibrillation. Pharmacogenomics and Personalized Medicine. Volume 14. 579–590. 8 indexed citations

Scherr, Johannes, Elham Kayvanpour, Jan Haas, et al.. (2021). Marathon-Induced Cardiac Strain as Model for the Evaluation of Diagnostic microRNAs for Acute Myocardial Infarction. Journal of Clinical Medicine. 11(1). 5–5. 1 indexed citations

Rahm, Ann‐Kathrin, Patrick Lugenbiel, Rasmus Rivinius, et al.. (2020). Inhibition of cardiac Kv4.3 (Ito) channel isoforms by class I antiarrhythmic drugs lidocaine and mexiletine. European Journal of Pharmacology. 880. 173159–173159. 5 indexed citations

Rahm, Ann‐Kathrin, Tanja Weis, Patrick Most, et al.. (2020). HDAC2-dependent remodeling of KCa2.2 (KCNN2) and KCa2.3 (KCNN3) K+ channels in atrial fibrillation with concomitant heart failure. Life Sciences. 266. 118892–118892. 14 indexed citations

Kayvanpour, Elham, Weng‐Tein Gi, Farbod Sedaghat‐Hamedani, et al.. (2020). microRNA neural networks improve diagnosis of acute coronary syndrome (ACS). Journal of Molecular and Cellular Cardiology. 151. 155–162. 18 indexed citations

Seyler, Claudia, Benjamin Meder, Tanja Weis, et al.. (2017). TranslatiOnal Registry for CardiomyopatHies (TORCH) – Rationale and First Results. ESC Heart Failure. 4(3). 209–215. 9 indexed citations

10.

Mueller‐Hennessen, Matthias, Jens C. Fuhrmann, Henning Witt, et al.. (2017). Metabolic Profiles in Heart Failure Due to Non-Ischemic Cardiomyopathy at Rest and Under Exercise. ESC Heart Failure. 4(2). 178–189. 21 indexed citations

11.

Basso, Daniela, Andrea Padoan, Thomas Laufer, et al.. (2016). Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling. Clinical Biochemistry. 50(4-5). 186–193. 21 indexed citations

12.

Lugenbiel, Patrick, Claudia Seyler, Derk Frank, et al.. (2016). TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control. Basic Research in Cardiology. 112(1). 8–8. 36 indexed citations

13.

Mueller‐Hennessen, Matthias, Hans‐Dirk Düngen, Matthias Lutz, et al.. (2016). A Novel Lipid Biomarker Panel for the Detection of Heart Failure with Reduced Ejection Fraction. Clinical Chemistry. 63(1). 267–277. 22 indexed citations

14.

Padberg, Inken, Erik Peter, Henning Witt, et al.. (2014). A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology. PLoS ONE. 9(1). e85082–e85082. 72 indexed citations

15.

Backes, Christina, Frank Rühle, Monika Stoll, et al.. (2014). Systematic permutation testing in GWAS pathway analyses: identification of genetic networks in dilated cardiomyopathy and ulcerative colitis. BMC Genomics. 15(1). 622–622. 18 indexed citations

16.

Kollman, Craig, et al.. (2001). Non-HLA barriers to unrelated donor stem cell transplantation. Bone Marrow Transplantation. 27(6). 581–587. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact